{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1390282680156005376.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.2133/dmpk.17.199"}},{"identifier":{"@type":"URI","@value":"http://api.elsevier.com/content/article/PII:S1347436715309344?httpAccept=text/xml"}},{"identifier":{"@type":"URI","@value":"http://api.elsevier.com/content/article/PII:S1347436715309344?httpAccept=text/plain"}},{"identifier":{"@type":"PMID","@value":"15618670"}},{"identifier":{"@type":"NAID","@value":"130004462832"}},{"identifier":{"@type":"NAID","@value":"50000598913"}},{"identifier":{"@type":"URI","@value":"https://search.jamas.or.jp/link/ui/2003034849"}}],"dc:title":[{"@language":"en","@value":"Metabolism of Selegiline Hydrochloride, a Selective Monoamine B-type Inhibitor, in Human Liver Microsomes"}],"dc:language":"en","description":[{"type":"abstract","notation":[{"@language":"en","@value":"The participation of cytochrome P-450 (CYP) isoforms in the metabolism of selegiline was investigated. Experiments using recombinant CYP isoforms expressed in human lymphoblastoid cells showed CYP2B6 to be the major CYP isoform involved with the metabolism of selegiline. CYP1A2 and CYP3A4 also contributed to the metabolism of selegiline but their catalytic activities were much less than that of CYP2B6. CYP2B6 had a higher affinity for both <i>N</i>-depropagylation (<i>K</i><sub>m</sub>=21.4 μM) and <i>N</i>-demethylation (<i>K</i><sub>m</sub>=25.2 μM) of selegiline than CYP3A4 and CYP1A2. In immunoinhibition studies using mixed human hepatic microsomes, selegiline <i>N</i>-depropagylation activity was most strongly inhibited by anti-CYP2B and anti-CYP3A antibodies, while selegiline <i>N</i>-demethylation activity was most inhibited by anti-CYP2B antibody. In CYP2B6-rich human hepatic microsomes, anti-CYP2B antibody had the strongest inhibitory effects on both activities. Selegiline inhibited CYP2B6-mediated (S)-mephenytoin <i>N</i>-demethylation activity and CYP2C19-mediated (S)-mephenytoin 4′-hydroxylation activity. These findings suggest that attention should be paid to the drug-drug interaction associated with CYP2B6 and CYP2C19.<br>   In conclusion, CYP2B6 participates in the metabolism of selegiline but the degree of its contribution varies with the level of its expression in human liver.<br>"}],"abstractLicenseFlag":"disallow"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1410282680156005379","@type":"Researcher","personIdentifier":[{"@type":"NRID","@value":"9000257889491"}],"foaf:name":[{"@language":"en","@value":"KAMADA Takahiro"}],"jpcoar:affiliationName":[{"@language":"en","@value":"Institute of Research and Development, Fujimoto Pharmaceutical Corporation"},{"@language":"en","@value":"Department of Chemical Biology, Osaka City University Medical School"}]},{"@id":"https://cir.nii.ac.jp/crid/1410282680156005382","@type":"Researcher","personIdentifier":[{"@type":"NRID","@value":"9000257889496"},{"@type":"NRID","@value":"9000011064357"}],"foaf:name":[{"@language":"en","@value":"OHDE Hironori"}],"jpcoar:affiliationName":[{"@language":"en","@value":"Institute of Research and Development, Fujimoto Pharmaceutical Corporation"}]},{"@id":"https://cir.nii.ac.jp/crid/1030003658557928832","@type":"Researcher","personIdentifier":[{"@type":"KAKEN_RESEARCHERS","@value":"00047268"},{"@type":"NRID","@value":"1000000047268"},{"@type":"NRID","@value":"9000005284731"},{"@type":"NRID","@value":"9000392000440"},{"@type":"NRID","@value":"9000002241697"},{"@type":"NRID","@value":"9000002745042"},{"@type":"NRID","@value":"9000005216566"},{"@type":"NRID","@value":"9000005217422"},{"@type":"NRID","@value":"9000391915667"},{"@type":"NRID","@value":"9000415159844"},{"@type":"NRID","@value":"9000004029130"},{"@type":"NRID","@value":"9000392743315"},{"@type":"NRID","@value":"9000392744165"},{"@type":"NRID","@value":"9000254869408"},{"@type":"NRID","@value":"9000391911366"},{"@type":"NRID","@value":"9000391915578"},{"@type":"NRID","@value":"9000391999838"},{"@type":"NRID","@value":"9000257891611"},{"@type":"NRID","@value":"9000258573371"},{"@type":"NRID","@value":"9000252831312"},{"@type":"NRID","@value":"9000258571519"},{"@type":"NRID","@value":"9000252860012"},{"@type":"NRID","@value":"9000252832076"},{"@type":"NRID","@value":"9000003099600"},{"@type":"NRID","@value":"9000391638652"},{"@type":"NRID","@value":"9000253263006"},{"@type":"NRID","@value":"9000020279937"},{"@type":"NRID","@value":"9000253262702"},{"@type":"NRID","@value":"9000257889497"},{"@type":"NRID","@value":"9000020280394"},{"@type":"NRID","@value":"9000004107013"},{"@type":"NRID","@value":"9000023422261"},{"@type":"NRID","@value":"9000253262731"},{"@type":"NRID","@value":"9000020955394"},{"@type":"NRID","@value":"9000020520488"},{"@type":"NRID","@value":"9000253163738"},{"@type":"NRID","@value":"9000254358339"},{"@type":"NRID","@value":"9000252832032"},{"@type":"NRID","@value":"9000254596940"},{"@type":"NRID","@value":"9000257889744"},{"@type":"NRID","@value":"9000254685407"},{"@type":"NRID","@value":"9000019976955"},{"@type":"NRID","@value":"9000254702465"},{"@type":"NRID","@value":"9000415162497"},{"@type":"NRID","@value":"9000391915674"},{"@type":"NRID","@value":"9000347046584"}],"foaf:name":[{"@language":"en","@value":"FUNAE Yoshihiko"}],"jpcoar:affiliationName":[{"@language":"en","@value":"Department of Chemical Biology, Osaka City University Medical School"}]},{"@id":"https://cir.nii.ac.jp/crid/1410282680156005380","@type":"Researcher","personIdentifier":[{"@type":"NRID","@value":"9000257889495"},{"@type":"NRID","@value":"9000011064354"}],"foaf:name":[{"@language":"en","@value":"MORIMOTO Kazuhiko"}],"jpcoar:affiliationName":[{"@language":"en","@value":"Institute of Research and Development, Fujimoto Pharmaceutical Corporation"}]},{"@id":"https://cir.nii.ac.jp/crid/1420564276183785856","@type":"Researcher","personIdentifier":[{"@type":"KAKEN_RESEARCHERS","@value":"30305643"},{"@type":"NRID","@value":"1000030305643"},{"@type":"NRID","@value":"9000003668074"},{"@type":"NRID","@value":"9000002243136"},{"@type":"NRID","@value":"9000415159843"},{"@type":"NRID","@value":"9000253017792"},{"@type":"NRID","@value":"9000257889493"},{"@type":"NRID","@value":"9000392755876"},{"@type":"RESEARCHMAP","@value":"https://researchmap.jp/20852"}],"foaf:name":[{"@language":"en","@value":"HIROI Toyoko"}],"jpcoar:affiliationName":[{"@language":"en","@value":"Department of Chemical Biology, Osaka City University Medical School"}]},{"@id":"https://cir.nii.ac.jp/crid/1030003658392279168","@type":"Researcher","personIdentifier":[{"@type":"KAKEN_RESEARCHERS","@value":"60145795"},{"@type":"NRID","@value":"1000060145795"},{"@type":"NRID","@value":"9000002186616"},{"@type":"NRID","@value":"9000005284730"},{"@type":"NRID","@value":"9000253164957"},{"@type":"NRID","@value":"9000391997261"},{"@type":"NRID","@value":"9000392000441"},{"@type":"NRID","@value":"9000258573135"},{"@type":"NRID","@value":"9000005217423"},{"@type":"NRID","@value":"9000391607381"},{"@type":"NRID","@value":"9000391609066"},{"@type":"NRID","@value":"9000283795982"},{"@type":"NRID","@value":"9000253170411"},{"@type":"NRID","@value":"9000391992435"},{"@type":"NRID","@value":"9000415146745"},{"@type":"NRID","@value":"9000415159838"},{"@type":"NRID","@value":"9000016807321"},{"@type":"NRID","@value":"9000006301952"},{"@type":"NRID","@value":"9000392743316"},{"@type":"NRID","@value":"9000392744166"},{"@type":"NRID","@value":"9000254869407"},{"@type":"NRID","@value":"9000252800431"},{"@type":"NRID","@value":"9000253165865"},{"@type":"NRID","@value":"9000397801779"},{"@type":"NRID","@value":"9000391999837"},{"@type":"NRID","@value":"9000397801939"},{"@type":"NRID","@value":"9000391997735"},{"@type":"NRID","@value":"9000257891612"},{"@type":"NRID","@value":"9000258573369"},{"@type":"NRID","@value":"9000259342585"},{"@type":"NRID","@value":"9000004564602"},{"@type":"NRID","@value":"9000021587009"},{"@type":"NRID","@value":"9000253165286"},{"@type":"NRID","@value":"9000252831311"},{"@type":"NRID","@value":"9000403274973"},{"@type":"NRID","@value":"9000258571517"},{"@type":"NRID","@value":"9000391640441"},{"@type":"NRID","@value":"9000347046533"},{"@type":"NRID","@value":"9000252860013"},{"@type":"NRID","@value":"9000252832070"},{"@type":"NRID","@value":"9000415175954"},{"@type":"NRID","@value":"9000415176131"},{"@type":"NRID","@value":"9000000689421"},{"@type":"NRID","@value":"9000003099597"},{"@type":"NRID","@value":"9000023241760"},{"@type":"NRID","@value":"9000391638650"},{"@type":"NRID","@value":"9000391630217"},{"@type":"NRID","@value":"9000253263005"},{"@type":"NRID","@value":"9000391995955"},{"@type":"NRID","@value":"9000020279926"},{"@type":"NRID","@value":"9000345266689"},{"@type":"NRID","@value":"9000253262703"},{"@type":"NRID","@value":"9000401627123"},{"@type":"NRID","@value":"9000410905715"},{"@type":"NRID","@value":"9000397799386"},{"@type":"NRID","@value":"9000391999889"},{"@type":"NRID","@value":"9000257889494"},{"@type":"NRID","@value":"9000257891023"},{"@type":"NRID","@value":"9000020280384"},{"@type":"NRID","@value":"9000021940133"},{"@type":"NRID","@value":"9000021328093"},{"@type":"NRID","@value":"9000383075308"},{"@type":"NRID","@value":"9000391630197"},{"@type":"NRID","@value":"9000253262725"},{"@type":"NRID","@value":"9000253163736"},{"@type":"NRID","@value":"9000254358338"},{"@type":"NRID","@value":"9000254695576"},{"@type":"NRID","@value":"9000252832031"},{"@type":"NRID","@value":"9000411115106"},{"@type":"NRID","@value":"9000243875823"},{"@type":"NRID","@value":"9000006703109"},{"@type":"NRID","@value":"9000006394462"},{"@type":"NRID","@value":"9000391630423"},{"@type":"NRID","@value":"9000253262710"},{"@type":"NRID","@value":"9000254596939"},{"@type":"NRID","@value":"9000392000434"},{"@type":"NRID","@value":"9000392726314"},{"@type":"NRID","@value":"9000242901928"},{"@type":"NRID","@value":"9000253167011"},{"@type":"NRID","@value":"9000252764659"},{"@type":"NRID","@value":"9000014276275"},{"@type":"NRID","@value":"9000283731604"},{"@type":"NRID","@value":"9000254702464"},{"@type":"NRID","@value":"9000391997746"},{"@type":"NRID","@value":"9000415162496"},{"@type":"NRID","@value":"9000338673018"},{"@type":"NRID","@value":"9000338673017"},{"@type":"NRID","@value":"9000391915672"},{"@type":"NRID","@value":"9000386307447"},{"@type":"NRID","@value":"9000253166085"},{"@type":"NRID","@value":"9000258571735"},{"@type":"RESEARCHMAP","@value":"https://researchmap.jp/read_2022"}],"foaf:name":[{"@language":"en","@value":"IMAOKA Susumu"}],"jpcoar:affiliationName":[{"@language":"en","@value":"Department of Chemical Biology, Osaka City University Medical School"}]},{"@id":"https://cir.nii.ac.jp/crid/1410282680156005376","@type":"Researcher","personIdentifier":[{"@type":"NRID","@value":"9000257889492"},{"@type":"NRID","@value":"9000011064349"}],"foaf:name":[{"@language":"en","@value":"CHOW Toshio"}],"jpcoar:affiliationName":[{"@language":"en","@value":"Department of Chemical Biology, Osaka City University Medical School"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"13474367"},{"@type":"EISSN","@value":"18800920"},{"@type":"NCID","@value":"AA1162652X"}],"prism:publicationName":[{"@language":"en","@value":"Drug Metabolism and Pharmacokinetics"},{"@language":"en","@value":"DMPK"},{"@language":"ja","@value":"Ｄｒｕｇ　Ｍｅｔａｂｏｌｉｓｍ　ａｎｄ　Ｐｈａｒｍａｃｏｋｉｎｅｔｉｃｓ"}],"dc:publisher":[{"@language":"en","@value":"The Japanese Society for the Study of Xenobiotics"},{"@language":"ja","@value":"日本薬物動態学会"}],"prism:publicationDate":"2002","prism:volume":"17","prism:number":"3","prism:startingPage":"199","prism:endingPage":"206"},"reviewed":"false","url":[{"@id":"http://api.elsevier.com/content/article/PII:S1347436715309344?httpAccept=text/xml"},{"@id":"http://api.elsevier.com/content/article/PII:S1347436715309344?httpAccept=text/plain"},{"@id":"https://search.jamas.or.jp/link/ui/2003034849"}],"availableAt":"2002","foaf:topic":[{"@id":"https://cir.nii.ac.jp/all?q=selegiline","dc:title":"selegiline"},{"@id":"https://cir.nii.ac.jp/all?q=human","dc:title":"human"},{"@id":"https://cir.nii.ac.jp/all?q=cytochrome%20P450","dc:title":"cytochrome P450"},{"@id":"https://cir.nii.ac.jp/all?q=drug-drug%20interactions","dc:title":"drug-drug interactions"}],"relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360004234888952832","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Functional characterization of 26 CYP2B6 allelic variants (CYP2B6.2–CYP2B6.28, except CYP2B6.22)"}]},{"@id":"https://cir.nii.ac.jp/crid/1360011143983763328","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Ketoconazole and sulphaphenazole as the respective selective inhibitors of P4503A and 2C9"}]},{"@id":"https://cir.nii.ac.jp/crid/1360011145195520768","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Highly sensitive high-performance liquid chromatographic assay for coumarin 7-hydroxylation and 7-ethoxycoumarin O-deethylation by human liver cytochrome P450 enzymes"}]},{"@id":"https://cir.nii.ac.jp/crid/1361699995276094464","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Assay of mephenytoin metabolism in human liver microsomes by high-performance liquid chromatography"}]},{"@id":"https://cir.nii.ac.jp/crid/1361981470279637504","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"The Effect of Deprenyl (Selegiline) on the Natural History of Parkinson's Disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1362825893897354624","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Selegiline Metabolism and Cytochrome P450 Enzymes:In vitro Study in Human Liver Microsomes*"}]},{"@id":"https://cir.nii.ac.jp/crid/1363107368751872640","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Metabolism of deprenyl, a selective monoamine oxidase (MAO) B inhibitor in rat: relationship of metabolism to MAO-B inhibitory potency"}]},{"@id":"https://cir.nii.ac.jp/crid/1363107370719623936","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Atypical Metabolism of Deprenyl and Its Enantiomer, (S)-(+)-N,.alpha.-Dimethyl-N-Propynylphenethylamine, by Cytochrome P450 2D6"}]},{"@id":"https://cir.nii.ac.jp/crid/1363388843436164352","@type":"Article","relationType":["references","cites"],"jpcoar:relatedTitle":[{"@value":"Simultaneous purification of multiple forms of rat liver microsomal cytochrome P-450 by high-performance liquid chromatography"}]},{"@id":"https://cir.nii.ac.jp/crid/1363388845022910720","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Effect of Deprenyl on the Progression of Disability in Early Parkinson's Disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1363670319131343360","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Hydroxylation of chlorzoxazone as a specific probe for human liver cytochrome P-450IIE1"}]},{"@id":"https://cir.nii.ac.jp/crid/1363670321120368640","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Evaluation of Triacetyloleandomycin, α-Nasymphthoflavone and Diethyldithiocarbamate as Selective Chemical Probes for Inhibition of Human Cytochromes P450"}]},{"@id":"https://cir.nii.ac.jp/crid/1363951793987162112","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Purification and characterization of two constitutive cytochromes P-450 (F-1 and F-2) from adult female rats: identification of P-450F-1 as the phenobarbital-inducible cytochrome P-450 in male rat liver"}]},{"@id":"https://cir.nii.ac.jp/crid/1363951796111317632","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Catalytic roles of rat and human cytochrome P450 2A enzymes in testosterone 7α- and coumarin 7-hydroxylations"}]},{"@id":"https://cir.nii.ac.jp/crid/1364233268887530368","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"CYP2D6 polymorphism is not crucial for the disposition of selegiline*"}]},{"@id":"https://cir.nii.ac.jp/crid/1364233270353937536","@type":"Article","relationType":["references","cites"],"jpcoar:relatedTitle":[{"@value":"The possible mechanisms of action of (-)deprenyl in Parkinson's disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1370848663324980609","@type":"Product","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Metabolism of selegiline in humans. Identification, excretion, and stereochemistry of urine metabolites"}]},{"@id":"https://cir.nii.ac.jp/crid/1370848663324980610","@type":"Product","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Bufuralol hydroxylation by cytochrome P450 2D6 and 1A2 enzymes in human liver microsomes"}]},{"@id":"https://cir.nii.ac.jp/crid/1370848663324980612","@type":"Product","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Tolbutamide and mephenytoin hydroxylation by human cytochrome P450s in the CYP2C subfamily"}]},{"@id":"https://cir.nii.ac.jp/crid/1370848663324980613","@type":"Product","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Contribution of CYP3A to selegiline metabolism in rat and human liver microsomes"}]},{"@id":"https://cir.nii.ac.jp/crid/1370848663324980614","@type":"Product","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Human cytochrome P450 enzymes and chemical carcinogenesis"}]},{"@id":"https://cir.nii.ac.jp/crid/1370848663324980619","@type":"Product","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Cytochrome P450 enzymes and selegiline: the in vitro study with selegiline and its metabolites in human liver microsomes"}]},{"@id":"https://cir.nii.ac.jp/crid/1370848663324980620","@type":"Product","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Inhibition of oxidative drug metabolism by orphenadrine: in vitro and in vivo evidence for isozyme-specific complexation of cytochrome P-450 and inhibition kinetics"}]},{"@id":"https://cir.nii.ac.jp/crid/1370848663324980737","@type":"Product","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"In vitro inhibition studies of two isozymes of human liver cytochrome P-450. Mephenytoin p-hydroxylase and sparteine monooxygenase"}]},{"@id":"https://cir.nii.ac.jp/crid/1370848663324980740","@type":"Product","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Catalytic role of cytochrome P4502B6 in the N-demethylation of S-mephenytoin"}]},{"@id":"https://cir.nii.ac.jp/crid/1370848663324980864","@type":"Product","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"CYP2B6 and CYP2C19 as the major enzymes responsible for the metabolism of selegiline, a drug used in the treatment of Parkinson's disease, as revealed from experiments with recombinant enzymes"}]},{"@id":"https://cir.nii.ac.jp/crid/1370848663324980866","@type":"Product","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Cytochrome P450 inhibitors. Evaluation of specificities in the in vitro metabolism of therapeutic agents by human liver microsomes"}]},{"@id":"https://cir.nii.ac.jp/crid/1370848663324980867","@type":"Product","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Mepyramine, a histamine H1 receptor antagonist, inhibits the metabolic activity of rat and human P450 2D forms"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282680158304640","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Predicting Oxidation Sites with Order of Occurrence among Multiple Sites for CYP4A-mediated Reactions"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282680158374784","@type":"Article","relationType":["isReferencedBy","isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"P450 Phenotyping of the Metabolism of Selegiline to Desmethylselegiline and Methamphetamine"}]},{"@id":"https://cir.nii.ac.jp/crid/1570009750132482688","@type":"Article","relationType":["cites"]},{"@id":"https://cir.nii.ac.jp/crid/1570291226766267008","@type":"Article","relationType":["cites"]},{"@id":"https://cir.nii.ac.jp/crid/1570572701710739328","@type":"Article","relationType":["cites"]},{"@id":"https://cir.nii.ac.jp/crid/1570572701713147392","@type":"Article","relationType":["cites"]},{"@id":"https://cir.nii.ac.jp/crid/1570572701713988352","@type":"Article","relationType":["cites"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Evaluation of triacetyloleandomycin, α-naphthoflavone and diethyldithiocarbamate as selective chemical probes for inhibition of human cytochromes P450."}]},{"@id":"https://cir.nii.ac.jp/crid/1571135651654965376","@type":"Article","relationType":["cites"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Metabolism of deprenyl, a selective monoamine oxidase (MAO) B inhibitor in rat : relationship of metabolism to MAO-B inhibitory protency"}]},{"@id":"https://cir.nii.ac.jp/crid/1571135651667544960","@type":"Article","relationType":["cites"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Atypical metabolism of deprenyl and its enantiomer, (S)-(+)-N, alpha-dimethyl-N-propynylphenethylamine, by cytochrome P450 2D6."}]},{"@id":"https://cir.nii.ac.jp/crid/1571417124673425408","@type":"Article","relationType":["cites"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Contribution of CYP3A to selegiline metabolism in rat and human liver microsomes."}]},{"@id":"https://cir.nii.ac.jp/crid/1571417126648343808","@type":"Article","relationType":["cites"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Catalytic roles of rat and human cytochrome P450 2A enzymes in testosterone 7α- and coumarin 7-hydroxylations"}]},{"@id":"https://cir.nii.ac.jp/crid/1571417126674457600","@type":"Article","relationType":["cites"]},{"@id":"https://cir.nii.ac.jp/crid/1571698601590025728","@type":"Article","relationType":["cites"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Purification and characterization of two constitutive cytochromes P-450 (F-1 and F-2) from adult female rats: identification of P-450F-1 as the Phenobarbital-inducible cytochrome P-450 in male rat liver."}]},{"@id":"https://cir.nii.ac.jp/crid/1571980076630040448","@type":"Article","relationType":["cites"]},{"@id":"https://cir.nii.ac.jp/crid/1571980076630995968","@type":"Article","relationType":["cites"],"jpcoar:relatedTitle":[{"@language":"en","@value":"CYP2D6 polymorphism is not crucial for the disposition of selegiline"}]},{"@id":"https://cir.nii.ac.jp/crid/1572261550711037952","@type":"Article","relationType":["cites"]},{"@id":"https://cir.nii.ac.jp/crid/1572543026603279872","@type":"Article","relationType":["cites"]},{"@id":"https://cir.nii.ac.jp/crid/1572824499556979200","@type":"Article","relationType":["cites"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Human cytochrome P450 enzymes and chemical carcinogenesis."}]},{"@id":"https://cir.nii.ac.jp/crid/1572824501506822912","@type":"Article","relationType":["cites"],"jpcoar:relatedTitle":[{"@language":"en","@value":"The effect of deprenyl (selegiline) on the natural history of Parkinson's disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1573105974533689856","@type":"Article","relationType":["cites"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Cytochrome P450 enzymes and selegiline: the in vitro study with selegiline and its metabolites in human liver microsomes."}]},{"@id":"https://cir.nii.ac.jp/crid/1573105976480671488","@type":"Article","relationType":["cites"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Inhibition of oxidative drug metabolism by orphenadrine: in vitro and in vivo evidence for isozyme-specific complexation of cytochrome P-450 and inhibition kinetics."}]},{"@id":"https://cir.nii.ac.jp/crid/1573668925599620608","@type":"Article","relationType":["cites"]},{"@id":"https://cir.nii.ac.jp/crid/1573668926445044224","@type":"Article","relationType":["cites"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Assay of mephenytoin metabolism in human liver microsomes by high-performance liquid chromatography."}]},{"@id":"https://cir.nii.ac.jp/crid/1573668926451809536","@type":"Article","relationType":["cites"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Tolbutamide and mephenytoin hydroxylation by human cytochrome P450s in the CYP2C subfamily"}]},{"@id":"https://cir.nii.ac.jp/crid/1573950401420793088","@type":"Article","relationType":["cites"],"jpcoar:relatedTitle":[{"@language":"en","@value":"In vitro inhibition studies of two isozymes of human liver cytochrome P-450 : Mephenytoin p-hydroxylase and sparteine monooxygenase"}]},{"@id":"https://cir.nii.ac.jp/crid/1573950401476616320","@type":"Article","relationType":["cites"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Highly sensitive HPLC assay for coumarin 7-hydroxylation and 7-ethoxycoumarin O-deethylation by human liver cytochrome P450 enzymes"}]},{"@id":"https://cir.nii.ac.jp/crid/1574231874440531584","@type":"Article","relationType":["cites"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Effect of deprenyl on the progression of disability in early Parkinson disease."}]}],"dataSourceIdentifier":[{"@type":"JALC","@value":"oai:japanlinkcenter.org:0024422839"},{"@type":"CROSSREF","@value":"10.2133/dmpk.17.199"},{"@type":"CIA","@value":"130004462832"},{"@type":"CIA","@value":"50000598913"},{"@type":"OPENAIRE","@value":"doi_dedup___::0060f50b3c4836c4f7cb3d1184f035ab"},{"@type":"CROSSREF","@value":"10.2133/dmpk.22.78_references_DOI_8NK8mYEuCMkxXpwpbYQYjbJwWGJ"},{"@type":"CROSSREF","@value":"10.2133/dmpk.dmpk-11-rg-004_references_DOI_8NK8mYEuCMkxXpwpbYQYjbJwWGJ"},{"@type":"CROSSREF","@value":"10.1097/fpc.0b013e32833bba0e_references_DOI_8NK8mYEuCMkxXpwpbYQYjbJwWGJ"}]}